BioSig Technologies, Inc. (BSGM)
USD 1.28
(-3.76%)
USD 1.28
(-3.76%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -17.31 Million | -21.7 Million | -26.39 Million | -26.6 Million | -15.48 Million | -10.25 Million |
| Net Income | -28.69 Million | -27.26 Million | -32.85 Million | -59.14 Million | -34.47 Million | -17.25 Million |
| Depreciation & Amortization | 361 Thousand | 293 Thousand | 198 Thousand | 550 Thousand | 54.34 Thousand | 12.4 Thousand |
| Deferred income taxes | -3.33 Million | - | -232 Thousand | - | - | - |
| Stock-based compensation | 7.97 Million | 4.41 Million | 9.5 Million | 25.16 Million | 15.17 Million | 6.6 Million |
| Change in working capital | 769 Thousand | 464 Thousand | -3.45 Million | 2.35 Million | -72.28 Thousand | 382.9 Thousand |
| Other non-cash items | 5.6 Million | 388 Thousand | 441 Thousand | 4.47 Million | 3.82 Million | 6.62 Million |
| Investing Cash Flow | -186 Thousand | -168 Thousand | -542 Thousand | -87 Thousand | -285.93 Thousand | -307.67 Thousand |
| Investments in PPE | -186 Thousand | -168 Thousand | -542 Thousand | -87 Thousand | -288.68 Thousand | -307.67 Thousand |
| Acquisitions | - | - | - | - | 2749.00 | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | -108 Thousand | -269.64 Thousand |
| Financing Cash Flow | 17.33 Million | 10.57 Million | 10.33 Million | 42.84 Million | 23.42 Million | 13.46 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -9000.00 | -9000.00 | -9000.00 | -180 Thousand | -399.59 Thousand | -744.45 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 15.36 Million | 10.35 Million | 10.3 Million | 27.44 Million | 10 Million | 9.13 Million |
| Other Financing Activities | 1.97 Million | 218 Thousand | 37 Thousand | 15.58 Million | 13.81 Million | 5.07 Million |
| Accounts receivables | -15 Thousand | -9000.00 | 1.98 Million | -3.23 Million | -537.49 Thousand | - |
| Accounts payables | 1.37 Million | 776.00 | -1.98 Million | 3.23 Million | 537.49 Thousand | 478.75 Thousand |
| Inventory | -498 Thousand | 284 Thousand | -1.11 Million | -287 Thousand | -577.69 Thousand | - |
| Other working capital | -88 Thousand | 188.22 Thousand | -2.33 Million | 2.63 Million | 505.4 Thousand | -95.85 Thousand |
| Cash at beginning of period | 357 Thousand | 11.65 Million | 28.26 Million | 12.1 Million | 4.45 Million | 1.54 Million |
| Cash at end of period | 190 Thousand | 357 Thousand | 11.65 Million | 28.26 Million | 12.1 Million | 4.45 Million |
| Capital Expenditure | -186 Thousand | -168 Thousand | -542 Thousand | -87 Thousand | -288.68 Thousand | -307.67 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -167 Thousand | -11.3 Million | -16.6 Million | 16.15 Million | 7.65 Million | 2.9 Million |
| Free Cash Flow | -17.49 Million | -21.87 Million | -26.94 Million | -26.68 Million | -15.77 Million | -10.56 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.91 Million | -3.4 Million | -6.12 Million | -28.69 Million | -4.05 Million | -11.13 Million |
| Depreciation & Amortization | 49 Thousand | 78 Thousand | 93 Thousand | 361 Thousand | 92 Thousand | 92 Thousand |
| Deferred income taxes | - | - | 669 Thousand | -3.33 Million | - | 1.3 Million |
| Stock-based compensation | 4.43 Million | 1.06 Million | 1.44 Million | 7.97 Million | -359 Thousand | 4.74 Million |
| Change in working capital | -3.51 Million | 632 Thousand | 901 Thousand | 769 Thousand | 417 Thousand | 21 Thousand |
| Other non-cash items | 78 Thousand | 1.49 Million | 77 Thousand | 5.6 Million | 72 Thousand | 73 Thousand |
| Investing Cash Flow | - | - | -4000.00 | -186 Thousand | -60 Thousand | -77 Thousand |
| Investments in PPE | - | - | -4000.00 | -186 Thousand | -60 Thousand | -77 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 3.16 Million | 1.54 Million | 2.74 Million | 17.33 Million | 3.02 Million | 4.81 Million |
| Debt repayment | - | -500 Thousand | - | - | - | - |
| Dividends payments | - | -2000.00 | -9000.00 | -9000.00 | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 3.16 Million | 1.04 Million | 2.74 Million | 15.36 Million | 2.62 Million | 3.24 Million |
| Other Financing Activities | - | 502 Thousand | 2.74 Million | 1.97 Million | 401 Thousand | 1.56 Million |
| Accounts receivables | -40 Thousand | 40 Thousand | -10 Thousand | -15 Thousand | 7000.00 | -4000.00 |
| Accounts payables | - | 705 Thousand | 1.34 Million | 1.37 Million | - | 43 Thousand |
| Inventory | - | - | -449 Thousand | -498 Thousand | -30 Thousand | -10 Thousand |
| Other working capital | 9000.00 | 592 Thousand | 16 Thousand | -88 Thousand | 440 Thousand | -8000.00 |
| Cash at beginning of period | 416 Thousand | 190 Thousand | 389 Thousand | 357 Thousand | 1.25 Million | 1.41 Million |
| Cash at end of period | 2.1 Million | 416 Thousand | 190 Thousand | 190 Thousand | 389 Thousand | 1.25 Million |
| Capital Expenditure | - | - | -4000.00 | -186 Thousand | -60 Thousand | -77 Thousand |
| Effect of forex changes on cash | - | - | -2.94 Million | - | 1.67 Million | 1.26 Million |
| Net cash flow / Change in cash | 1.68 Million | 226 Thousand | -199 Thousand | -167 Thousand | -863 Thousand | -160 Thousand |
| Free Cash Flow | -1.48 Million | -1.31 Million | -2.94 Million | -17.49 Million | -3.88 Million | -4.97 Million |
003816
002327
GLANCE
7953
INL
MUKKA